Objective: To identify the substances used by people who die from suicide by overdose in Toronto and to determine the correlates of specific categories of substances used.
Abbreviations
S uicide is the 10th most common cause of death in Canada and the 11th most common in the United States. 1, 2 In the United States, 18 .8% of all suicides are completed by overdose. 3 There are few studies that have systematically examined the substances used in suicides by overdose. Studies conducted in the United States and Australia have found opioids, TCAs, BDZs, alcohol, and illegal drugs, such as cocaine and amphetamines, to be the most commonly used drugs in suicide by overdose. [4] [5] [6] The only Canadian study 7 to examine toxicology in overdose examined death by all causes, split about evenly between suicide and nonsuicide, and found that the most common substances detected were alcohol, ADs, OTC medications, opioid analgesics, and BDZs. One important limitation of these studies is that they often report rates of suicide by overdose by a particular type of medication, such as ADs, but do not specify the specific medication or, in some cases, class of AD involved. Further, no studies have examined whether certain demographic and clinical variables are associated with overdose with different types of medications.
Having information on specific substances may be a key tool for understanding suicide as it could be used to design better suicide prevention efforts. 4, 8 It follows that if more detailed data were available, then more specific recommendations for reducing suicides by overdose could be offered to clinicians as well as pharmacists who provide the public with medications.
Toronto is Canada's largest city and has about 250 suicides per year, 9 many of which are by overdose. All data on suicide are collected by a single coroner's office, applying the same protocol and toxicological analysis for each death. This is an observational study without a specific hypothesis. Its aim was to collect the most detailed toxicological, clinical, and demographic data associated with suicide by overdose in Toronto to better inform suicide prevention strategies for the future.
Methods
We examined records at the Office of the Chief Coroner of Ontario covering suicides by overdose in Toronto from 1998 to 2007, inclusive. The population of Toronto during this time period was about 2.5 million. 10 Data were not collected past 2007 because it can take more than 2 years for all cases to be closed and thus data beyond 2007 were incomplete at the time of data collection. To be included, the death had to be ruled a suicide by the coroner's office according to the standard of a high degree of probability. Only overdoses that took place within the City of Toronto were included.
Staff at the coroner's office provided charts for all cases coded as suicides by overdose in Toronto for each year included in the study. After a process of standardizing data extraction for the first 10 cases, 2 coauthors then independently extracted information from the remainder of the charts. The coauthors extracted data side-by-side and were engaged in frequent discussion throughout to ensure that coding was done uniformly, in particular when ambiguous or unanticipated data were encountered. Each chart contained a toxicology report, which included all of the substances detected in the person's blood and urine when collected by the coroner (including levels), a determination as to whether that substance was present at a level that could cause death, and whether the level was above, at, or below what would be expected for someone taking that medication as normally prescribed. The pathologist then used this information to make a determination as to which substance(s) were responsible for the suicide in each case. Such determinations are complex, requiring detailed knowledge of a given case, as they depend on the deceased's medical history as well as drug levels, which are not always analogous to those found in living people and are influenced by the timing of bodily fluid retrieval. Therefore, we relied exclusively on the pathologist's determination in each case rather than arriving at our own conclusions from toxicology reports. In a small number of cases, typically where a number of substances were present in nonlethal levels, the pathologist concluded the cause of death was multiple drug toxicity, without specifying which specific substances were
Clinical Implications
• Psychiatrists should be cautious in prescribing large quantities of potentially lethal medications to at-risk patients.
• Nonpsychiatrist physicians treating patients with pain disorders and chronic diseases should screen patients for suicide risk.
• Physicians and pharmacists should take note of increased use of opioids and diphenhydramine for suicide.
Limitations
• Coroner's records may be prone to bias, which could have had an influence on results.
• This study did not examine deaths classified under categories other than suicide, such as natural death, accident, or homicide.
• Certain diagnoses, such as bipolar, anxiety, and personality disorders, are almost certainly underreported owing to limitations in coroner's records.
responsible. These suicides were included but without a specific substance as the cause of death.
Specific data extracted from the charts included substance(s) deemed by the pathologist to be responsible for the death, the number and type of substances detected in the toxicology screen, demographic data (age, sex, marital status and living situation), details surrounding the suicide (place of death and presence of a suicide note), and whether there was a reported history of major Axis I psychiatric disorders (mood disorders, anxiety disorders, or psychotic disorders), substance abuse (any documented history of drug or alcohol addiction), personality disorders, past suicide attempts, or general medical conditions (for example, pain, cancer, diabetes, or hypertension). Psychiatric and medical history included data from interviews with relatives and (or) acquaintances, which were nearly always conducted in the course of the coroner's investigation. These interviews were either conducted by the coroner or present in police reports obtained by the coroner. In a minority of cases, the coroner interviewed physicians and rarely information was gleaned directly from medical records.
ADs (SSRIs or SNRIs, TCAs, and others-bupropion, maprotiline, mirtazapine, moclobemide, nefazodone, and trazodone), sedative hypnotics or anxiolytics (BDZs, barbiturates, and zopiclone), mood stabilizers (lithium, divalproex sodium, carbamazepine, and gabapentin), and antipsychotics were considered psychotropic prescription medications. All other prescription medication, such as opioids, beta-blockers, and antiarrhythmics, were considered other prescription medication. Although some of these medications do have central nervous system effects, they are typically prescribed for their other effects by nonpsychiatrist physicians; therefore, they are collectively treated as other. Medications available without a prescription were considered OTC, and substances that are illegal in Canada (for example, cocaine or heroin) were classified as illegal drugs. Given the goal of providing the most clinically useful information, when acetaminophen and codeine were detected in a person known to be taking Tylenol 3, this was counted as other prescription medications and an opioid analgesic. Likewise, heroin, despite being an opioid, was included as an illegal drug. Having a psychiatric disorder or substance abuse listed on the chart was considered a history of mental illness. People who had a history of BD with or without mention of depression were coded as having BD. People with a history of depression in the chart without mention of BD were coded as having depression.
There were 427 charts coded as suicides by overdose out of a total of 2442 suicides by all methods during the study period. Among the 427 suicides by overdose, 25 were excluded because the overdose did not occur in Toronto, 3 were excluded because the death had been mislabelled a suicide on the coroner's computer system and was found to be due to another cause when the charts were reviewed, 1 was excluded because there was no information in the chart, and 1 was excluded because the chart was unavailable. This left a total of 397 suicides that were included (representing 199 men, 197 women, and 1 undetermined sex). Percentages in the results are all from this denominator of 397.
This research received ethics approval from the University of Toronto's Office of Research Ethics.
Statistical Analysis
Pairwise comparisons for demographic data as well as post hoc analyses were made using 2-sided chi-square tests for categorical variables and 2-sided independent t tests for continuous variables. Post hoc exploratory analyses were conducted comparing suicide deaths by overdose by psychotropic, compared with other prescription medication; prescription, compared with OTC medication; major psychiatric medication (AD, antipsychotic or mood stabilizer), compared with sedative hypnotic; and opioid, compared with nonopioid, nonpsychotropic prescription medication. Given that the analyses were exploratory, we maintained a threshold for significance of 0.05. All statistics were performed using SPSS Version 12.0 (SPSS Inc, Chicago, IL).
Results

Demographic Data and Other Features of the Suicide
Demographic data are shown in Table 1 and Figure 1 . There were no significant demographic or clinical differences between males and females who died by suicide by overdose. There was a trend toward females being more likely to be reported to have BD, which bordered on significance (females: 12.2%, compared with males: 6.5%, χ 2 = 3.73, df = 1, P = 0.05). Only 21% of people dying by suicide due to overdose were married. The most common location of death was a person's residence (n = 283, 72.4%), with a smaller number of people dying in hospital (n = 71, 18.2%) or at another location (n = 37, 9.5%). One hundred and fifty-two people (38.3%) left a suicide note.
Substances Used in Suicides by Overdose
More than one-half of the 397 suicides were determined to have only 1 substance as the cause of death (51.9%), with 90 suicides having 2 lethal substances (22.7%), and the remainder having 3 or more lethal substances (20.2%) or being ruled as mixed toxicity, without specifying the number and type of substances considered lethal (5.3%). The classes of lethal substances used as well as the most common specific substances are shown in Figure 2 .
Additional substances were detected in nonlethal amounts in 55% of cases, with an average of 2.1 substances found per case.
Opioid analgesics (28.2%), sedative hypnotic or anxiolytic medications (26.4%), OTC medications (21.4%), and TCAs (20.4%) were the most frequently detected specific classes of lethal substances. In suicides where only one class of substance was present in lethal amounts, OTC medication (12.1%), opioid analgesics (11.1%), and TCAs (11.1%) were the most common, whereas, individually, mood stabilizers (1.0%), and alcohol and illegal drugs (0.25% and 0.5%, respectively) were rarely the only type of substance causing death. In the other prescription category, the most common lethal nonopioid substance was diltiazam (3%). Diltiazem was considered the sole cause of death in 8 of those 12 cases. Diphenhydramine (14.4%), amitriptyline (12.3%), and alcohol (9.8%) were the most common specific substances detected in lethal amounts. While there were 53 cases where an SSRI, SNRI, and (or) another newer AD was present in lethal amounts, in 10 cases 1 or more of these medications were considered the sole lethal cause of death. Venlafaxine was present in 5 cases, citalopram in 3 cases, bupropion in 2 cases, and mirtazapine, sertraline, paroxetine, and fluvoxamine were each present in 1 case. In general, there were no large changes over time in the classes of medications used in suicide by overdose. A moderate reduction in the number of suicides by TCA overdose was observed between the earlier and later parts of the study (48 suicides from 1998 to 2002 and 33 from 2003 to 2007).
Post hoc, pairwise exploratory analyses demonstrated that people dying from suicide using psychotropic prescription medication were more often male (60.0%, compared with 48.4%, χ 2 = 3.95, df = 1, P = 0.05) and more likely to have a history of major mental illness (70.0%, compared with 58.6%, χ 2 = 4.18, df = 1, P = 0.04), than those dying from other prescription or OTC medications. People dying from suicide using any prescription medication were more likely to be married (25.5%, compared with 4.2%, χ 2 = 10.8, df = 1, P = 0.001), have a history of suicide attempts (45.8%, compared with 22.9%, χ 2 = 8.81, df = 1, P = 0.003), and a history of a general medical condition (42.3%, compared with 25.0%, χ 2 = 5.14, df = 1, P = 0.02) than people dying from OTC medications. People who used ADs, mood stabilizers, or antipsychotics tended to be younger (46.7, compared with 59.4, t = 4.82, df = 120, P < 0.001) and more likely to have a history of major mental illness (76.7%, compared with 53.1%, χ 2 = 6.29, df = 1, P = 0.01), compared with people who used sedative hypnotics who were older with a higher rate of general medical conditions (56.3%, compared with 31.1%, χ 2 = 6.35, df = 1, P = 0.01). Finally, people who died using opioid analgesics had higher rates of substance abuse (31.9%, compared with 8.0%, χ 2 = 5.18, df = 1, P = 0.02) while those dying using other nonpsychiatric prescription medications, such as antihypertensives and antiarrythmics, were more likely to have a history of a general medical condition (68.0%, compared with 42.6%, χ 2 = 5.23, df = 1, P = 0.04).
Discussion
Lethal Substances Used
This research has important implications for clinicians and pharmacists. One key finding is that opioid analgesics were the most common class of substances found in suicide by overdose. Previous epidemiologic studies have shown that opioids have recently become a common cause of unintentional overdose death. 11 Our work confirms that they are also an important cause of intentional overdose death. c These diagnoses are based on facts communicated to the coroner by family members, acquaintances and (or), in rare instances, physicians and medical records. It is possible that in some of these cases, the coroner was inadvertently provided with an incorrect diagnosis. www.LaRCP.ca b The number of deaths by suicide using diphenhydramine, acetaminophen, and salicylates exceeds the total number of OTC deaths as multiple drugs were used in some overdoses. Therefore, the total per cent of overdose suicides by acetaminophen is represented by its own shaded area plus the shaded area between acetaminophen and salicylates. Likewise, the per cent of overdoses by salicylates is represented by its own shaded area plus the shaded area between acetaminophen and salicylates.
Given their increasing use, guidelines have recently been developed regarding prescription of opioids in noncancer pain. 12 They recommend that "physicians should assess their patients for depression and suicidal ideation, and opioids should be dispensed in small amounts for patients at risk." 12, p 57 Our findings support the use of caution while prescribing these medications to high-risk patients. Our post hoc analyses indicate that this may be particularly important in patients with a history of substance abuse. We also suggest that similar recommendations should be made to physicians who prescribe other medications commonly used in suicide by overdose, such as sedative hypnotics or anxiolytics and TCAs. Note that, although these medications are frequently prescribed by psychiatrists, they are also prescribed by family physicians and various specialists as sleeping aids and for other nonpsychiatric indications, such as pain. Therefore, all physicians must be aware of the lethality associated with overdose of these medications.
Suicide is associated with psychiatric illness in most cases, 8 hence it is not surprising that many of the medications found in lethal amounts are indicated for psychiatric disorders. Sedative hypnotic medications and TCAs were often found in suicide by overdose, which is likely an indication of very common use of the former medications and a higher relative lethality of the latter. Given that SSRIs, SNRIs, and other newer ADs are considered to be relatively safe in overdose, it is notable that we identified 10 cases where the only type of lethal substances detected came from 1 of these AD categories. This finding demonstrates that these medications can be lethal in sufficient quantities and clinicians should be mindful of this when prescribing them to at-risk patients, particularly those with prior history of suicide attempts. This caution may be greater for specific SSRIs, SNRIs, and other newer ADs. A recent analysis of suicides in the United Kingdom according to most deaths per prescription showed that venlafaxine, mirtazapine, and citalopram were most likely to be used in lethal overdose. 13 Our research would seem to support this finding, with 7 of the 10 cases having at least 1 of those 3 substances present. Findings of higher suicide rates with the SSRI citalopram are particularly noteworthy given emerging evidence that daily doses of citalopram exceeding 40 mg may cause prolonged QT intervals and increase the risk of arrhythmia. 14 Note that depression is often underdiagnosed in people who die by suicide 8, 15 and it may be that suicides could have been prevented with proper AD treatment. Likewise, it may be that inadequate pain control results in more suicides by opioid overdose. Physicians should not necessarily avoid specific medications based on the findings presented here, but rather should advocate that at-risk patients with chronic pain and other general medical conditions receive optimized treatment. Likewise, physicians prescribing pain medications and TCAs, for example, should ensure that they have appropriately screened and managed patients' psychiatric illness and suicide risk. All physicians should exercise caution in prescribing potentially lethal medications to high-risk patients and provide careful follow-up where appropriate.
The most common specific substance deemed to have caused suicides was diphenhydramine, an OTC medication that is common in sleep aids. It was present in lethal quantities in 14% of all suicides. There have been numerous case reports of diphenhydramine toxicity resulting in death and at least 1 larger study, 16 over a 13-year period in Berlin, where 55 fatal diphenhydramine poisonings were reported with an unspecified majority of those being suicides. Historically, acetaminophen has tended to be the most common OTC medication used worldwide in intentional overdose 17 and, in England and Wales, it accounted for at least 200 deaths in 1997 alone. 18 Although overdose deaths did occur in our sample with acetaminophen, diphenhydramine was greater than 3 times more likely to be present and determined to be the cause of death, either alone or in combination with another substance.
Given the high rate of diphenhydramine-associated suicides, one key consideration is whether it would be helpful to promote means restriction by limiting access to diphenhydramine-based medications. Programs to limit dispensed quantities of acetaminophen in the United Kingdom were initially thought to reduce suicides 19 though more recent reviews have argued that the evidence is equivocal or does not support the notion that these efforts reduced the total number of suicide deaths, though it did reduce deaths by overdose. 20, 21 Nevertheless, at a minimum, physicians and pharmacists should be made aware that diphenhydramine has become one of the most commonly used medications in suicide by overdose.
Also note that there were a relatively large number of suicides using diltiazem, compared with other antihypertensive agents or indeed any other nonopioid, other prescription medication. This may be because diltiazem is a common medication that is frequently fatal in overdose, 22, 23 though it is not possible to determine the degree to which uncommon psychiatric side effects of diltiazem, such as psychosis or mania, 24 may have contributed to this finding. Regardless, physicians treating cardiac patients should take note of this finding and could consider avoiding using diltiazem in patients with a history of severe mental illness and (or) suicide attempts.
Our post hoc analyses yield intuitive results, though they require prospective replication. It appears the key message is that people die from overdose using the medication that one would expect (that is, psychotropic prescription medications are used more often by people with psychiatric illness, whereas other prescription medications are used more often by people with a history of a general medical condition). This underscores the potential that physicians prescribing these medications have to screen and attempt to intervene in patients at-risk for suicide. One example would be increasing care when prescribing BDZs to older, medically unwell patients who are depressed or have a history of suicidal ideation or attempts. The finding that www.LaRCP.ca OTC suicide deaths by overdose occurred more frequently in younger people with no history of suicide attempts may make this a population that is less amenable to an intervention as overdoses by this method may be even harder to predict. Finally, several recent studies have shown that suicide is becoming more common in the middleaged, a group previously thought to be at a lower risk for suicide. 25, 26 In keeping with those results, our study found that the most common age group for suicide by overdose was between 40 and 59 years.
Limitations
This research comes with important limitations. First, given the complexity of the process by which a cause of death was determined, it was necessary to rely on the conclusions of pathologists at the coroner's office and these conclusions could not be independently verified. Particularly in cases where multiple substances were present, it may have been challenging to determine which specific substance or combinations thereof contributed to the death. This limits these findings, which are based only on substances considered by the pathologist to have caused death. Further, we did not examine deaths classified under categories other than suicide, such as natural death, accident, homicide, or undetermined cause of death. Coroner's records may be prone to bias, which could have had an influence on results. For example, deaths in the elderly may be more likely to be misidentified as natural deaths. Moreover, there were relatively few deaths from suicide using an illegal drug, such as cocaine or amphetamines. It may be that some deaths by these substances were incorrectly determined to be accidental. Nevertheless, coroners are the experts on determining a cause of death and they were unbiased by the goals of our study. Coroner's reports are also necessarily focused on determining a cause of death. Information relevant to this determination, such as the presence or absence of a suicide note, is likely to be highly reliable; however, other details, such as specific psychiatric diagnoses, may be less reliable. Certain diagnoses are almost certainly underrepresented. Some people characterized as having depression by the coroner may in fact have been suffering from BD and the near absence of reported anxiety and personality disorders, conditions well known to be frequent in people who die from suicide, 27, 28 underscores the need for caution in interpreting diagnostic data from our study. Further, coroner's records rarely included information on who prescribed the medications used or their indications. As in any ecological study, the results of our work may have been influenced by chance fluctuations in rates of certain types of overdoses or other uncontrolled societal factors. Substances used in suicides by overdose will change over time and geographic region, hence it is not clear to what extent this data are generalizable to other regions, although the pattern of substances used for suicide by overdose in Toronto during this period are generally in keeping with those reported elsewhere. [5] [6] [7] Finally, this is an observational study and therefore all of our post hoc findings require confirmation with prospective trials.
Conclusion
Our study examined nearly 400 suicides by overdose over a 10-year period and found that the most commonly used substances were opioid analgesics, OTC medications, particularly diphenhydramine, sedative hypnotics or anxiolytics, and TCAs. Nonpsychiatrist physicians, psychiatrists, and purveyors of OTC medications should take note of these trends and take extra care in prescribing and dispensing these medicines to people at-risk of suicide.
